BioSpace News Archive

Press Releases

Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026

October 27, 2026
·
5 min read
Press Releases

CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union

October 27, 2026
·
8 min read
Press Releases

Actuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering

October 27, 2026
·
4 min read
Press Releases

Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline

October 27, 2026
·
6 min read
Press Releases

Helus Pharma Announces Co-Founders’ Transition from Executive Leadership as Company Advances Toward Next Stage of Development

October 27, 2026
·
8 min read
Press Releases

Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories

October 27, 2026
·
5 min read
Press Releases

Madrigal to Present Multiple Abstracts at AASLD’s The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH

October 27, 2026
·
12 min read
Press Releases

Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results

October 27, 2026
·
1 min read
Press Releases

Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution

October 27, 2026
·
7 min read
Press Releases

Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026

October 27, 2026
·
3 min read